FDA allows wide use of plasma for COVID-19 with little data that it works

Last week, the U.S. Food and Drug Administration (FDA) announced that it would not allow widespread use of blood plasma to treat COVID-19 patients without more evidence that the therapy works. Yesterday (Aug. 23), the agency apparently reversed this decision and…